A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University People's Hospital, Beijing, China
Contact: Study coordinator (Peking University People's Hospital) · pkuphiao@163.com · +86 010-88324516

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE2

Beverly Hills, United States · La Palma, United States

A Study of E6742 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE2

Bengbu, China · Beijing, China

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Los Angeles, United States

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus · Lupus Nephritis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orange, United States · Sacramento, United States